ATI LPN
ATI PN Comprehensive Predictor
1. How should a healthcare provider manage a patient with dehydration?
- A. Monitor fluid intake
- B. Encourage oral rehydration
- C. Administer IV fluids
- D. All of the above
Correct answer: D
Rationale: Dehydration management involves a comprehensive approach that includes monitoring fluid intake to assess the severity of dehydration, encouraging oral rehydration to replenish fluids orally if the patient can tolerate it, and administering IV fluids in severe cases where oral intake is insufficient. Choosing just one of these options may not address the diverse needs of patients with dehydration. Therefore, selecting 'All of the above' is the most appropriate response as it encompasses the various strategies required for effective dehydration management.
2. What are the key differences between systolic and diastolic heart failure?
- A. Systolic: Reduced ejection fraction; Diastolic: Preserved ejection fraction
- B. Systolic: Preserved ejection fraction; Diastolic: Reduced ejection fraction
- C. Systolic: Right-sided heart failure; Diastolic: Left-sided heart failure
- D. Systolic: Pulmonary congestion; Diastolic: Systemic congestion
Correct answer: A
Rationale: The correct answer is A. Systolic heart failure is characterized by reduced ejection fraction, meaning the heart is not pumping effectively. Diastolic heart failure, on the other hand, is characterized by preserved ejection fraction, indicating that the heart has difficulty relaxing and filling properly. Choices B, C, and D are incorrect because they do not accurately describe the key differences between systolic and diastolic heart failure.
3. What is the priority for a client with dehydration?
- A. Administer antiemetics to prevent nausea
- B. Monitor electrolyte levels to prevent imbalances
- C. Administer oral rehydration solutions
- D. Administer intravenous fluids
Correct answer: B
Rationale: The priority for a client with dehydration is to monitor electrolyte levels to prevent imbalances. Dehydration can lead to electrolyte disturbances, which can have serious consequences. Administering antiemetics (Choice A) may help with nausea but does not address the root cause of dehydration. Administering oral rehydration solutions (Choice C) can be beneficial, but monitoring electrolyte levels is crucial in managing dehydration. Administering intravenous fluids (Choice D) is important in severe cases of dehydration, but monitoring electrolytes should come first to assess the extent of the imbalance and guide fluid replacement therapy effectively.
4. When using restraints for an agitated/aggressive patient, which of the following statements should NOT influence the nurse's actions during this intervention?
- A. The institution's restraints/seclusion policies
- B. The patient's competence
- C. The patient's voluntary/involuntary status
- D. The patient's nursing care plan
Correct answer: C
Rationale: The correct answer is C because the patient's voluntary or involuntary status should not impact the nurse's actions when using restraints. The use of restraints should be based on the patient's behavior and the need to ensure their safety and the safety of others. Choices A, B, and D are important factors that should influence the nurse's actions. The institution's restraints/seclusion policies provide guidelines on the appropriate use of restraints, the patient's competence helps determine their understanding and ability to control their behavior, and the patient's nursing care plan guides the overall care provided, including the use of restraints if necessary.
5. A nurse is assessing a client who is prescribed spironolactone. Which of the following laboratory values should the nurse monitor for this client?
- A. Total bilirubin.
- B. Urine ketones.
- C. Serum potassium.
- D. Platelet count.
Correct answer: C
Rationale: The correct answer is C: Serum potassium. Spironolactone is a potassium-sparing diuretic, meaning it helps the body retain potassium. Therefore, the nurse should monitor the client's serum potassium levels to prevent hyperkalemia, which can be a potential side effect of spironolactone. Monitoring total bilirubin levels (A) is not specifically required for clients taking spironolactone. Urine ketones (B) are not directly influenced by spironolactone use. Platelet count (D) is not typically monitored in clients taking spironolactone.
Similar Questions
Access More Features
ATI LPN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI LPN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access